TXMD

TherapeuticsMD, Inc. · Healthcare

Insiders bought $14K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Dec 29, 2025

Insider Buying

$14K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Latest filing

Dec 29, 2025

Thompson Tommy G

TherapeuticsMD, Inc. (TXMD) has 1 SEC Form 4 filing (1 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Dec 29, 2025.

Inside the rolling window, 1 insider at TherapeuticsMD, Inc. reported 1 open-market purchase totaling $14K and no open-market sales. The most recent open-market filing is a purchase of 8,400 shares by Director Thompson Tommy G, dated Dec 23, 2025, worth $14K.

  • Industry:Drug Manufacturers - Specialty & Generic
  • CEO:Marlan D. Walker
  • Employees:1
  • HQ:Boca Raton, FL, US
  • IPO:2007-05-09
Source
Thompson Tommy G
Purchase$14KDec 29SEC ↗
Showing 1–1 of 1
1 / 1

Earnings: last 7 quarters

EstimatedActual

Frequently asked questions

How many SEC Form 4 insider filings does TXMD have?

TherapeuticsMD, Inc. (TXMD) has 1 SEC Form 4 filing (1 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Dec 29, 2025.

When was the most recent SEC Form 4 filing for TXMD?

The most recent Form 4 filing for TXMD on Tracefour is dated Dec 29, 2025.

What is the net insider flow at TXMD over the last 6 months?

Over the trailing 180 days, insiders at TXMD have net bought $14K based on SEC Form 4 disclosures.

What is the total insider buy and sell value at TXMD in the current window?

Inside the rolling window, insiders at TXMD bought $14K and sold $0 based on SEC Form 4 filings.

Can I get alerts for TXMD insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at TherapeuticsMD, Inc. (TXMD). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

TherapeuticsMD, Inc. is in the Healthcare sector.